SLC34A1 and SLC12A3 that were found to be more involved in the transmembrane transporter activities terms have been studied as potential targets for the clinical diagnosis, prognosis, and treatment of ccRCC patients [55]. The gene discussed is SLC34A1; the disease is nonpapillary renal cell carcinoma.